We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
+0.5%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$4.47B
AUM Growth
+$214M
Cap. Flow
+$244M
Cap. Flow %
5.46%
Top 10 Hldgs %
56.7%
Holding
106
New
9
Increased
24
Reduced
23
Closed
7

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$117M
2
ZTO icon
ZTO Express
ZTO
+$81.4M
3
B
Barrick Mining
B
+$58.6M
4
MOMO
Hello Group
MOMO
+$43.8M
5
WUBA
58.com Inc
WUBA
+$27.2M

Top Sells

Rank Stock Value
1
OC icon
Owens Corning
OC
+$91.9M
2
META icon
Meta Platforms (Facebook)
META
+$40.6M
3
MLCO icon
Melco Resorts & Entertainment
MLCO
+$14M
4
FTI icon
TechnipFMC
FTI
+$10.1M
5
CF icon
CF Industries
CF
+$9.46M

Sector Composition

Rank Sector Weight
1 Communication Services 25.75%
2 Technology 20.29%
3 Consumer Discretionary 17.17%
4 Industrials 14.18%
5 Energy 7.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALEC icon
76
Alector
ALEC
$199M
$1.34M 0.03%
92,933
-27,926
-23% -$504K
CCL icon
77
Carnival Corporation Ltd
CCL
$39.7B
$1.28M 0.03%
29,260
– –
RCUS icon
78
Arcus Biosciences
RCUS
$3.64B
$1.25M 0.03%
136,893
-9,300
-6% -$74.7K
ADI icon
79
Analog Devices
ADI
$190B
$1.2M 0.03%
10,720
– –
INFI
80
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$1.17M 0.03%
1,137,647
– –
EBAY icon
81
eBay
EBAY
$49.8B
$1.11M 0.02%
28,417
– –
PVLA
82
Palvella Therapeutics
PVLA
$2.27B
$1.04M 0.02%
3,798
-1,180
-24% -$457K
JD icon
83
JD.com
JD
$44.5B
$1.01M 0.02%
35,800
– –
BPMC
84
DELISTED
Blueprint Medicines
BPMC
$936K 0.02%
12,746
– –
NTLA icon
85
Intellia Therapeutics
NTLA
$1.67B
$883K 0.02%
66,170
-54,684
-45% -$872K
XLNX
86
DELISTED
Xilinx Inc
XLNX
$883K 0.02%
9,209
– –
ROKU icon
87
Roku
ROKU
$22.7B
$753K 0.02%
7,398
-2,703
-27% -$331K
DERM
88
DELISTED
Dermira, Inc.
DERM
$743K 0.02%
116,325
– –
FPRX
89
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$741K 0.02%
191,237
– –
ASLN
90
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$719K 0.02%
10,386
– –
APPN icon
91
Appian
APPN
$2.48B
$508K 0.01%
+10,693
New +$501K
FULC icon
92
Fulcrum Therapeutics
FULC
$297M
$498K 0.01%
+75,000
New +$830K
TWLO icon
93
Twilio
TWLO
$36.6B
$465K 0.01%
4,229
– –
OVID icon
94
Ovid Therapeutics
OVID
$491M
$420K 0.01%
+129,600
New +$295K
CRTO icon
95
Criteo S.A. Ordinary Shares
CRTO
$923M
$384K 0.01%
20,551
– –
LBTYA icon
96
Liberty Global Class A
LBTYA
$3.6B
$366K 0.01%
14,800
– –
NTGR icon
97
NETGEAR
NTGR
$635M
$229K 0.01%
7,100
– –
ARLO icon
98
Arlo Technologies
ARLO
$1.65B
$48K ﹤0.01%
14,060
– –
STOK icon
99
Stoke Therapeutics
STOK
$2.11B
$21K ﹤0.01%
1,000
– –
BIDU icon
100
Baidu
BIDU
$37.2B
– –
-64,264
Closed -$7.54M
1 2 3
4
5

Similar funds

LCG
Lisanti Capital Growth New York $397M AUM 178.66% 1-Year Est. Return
EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
GPC
Greenstone Partners & Co Larkspur, California $395M AUM 35.56% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Platinum Investment Management's Q3 2019 Portfolio in Review

As of Q3 2019, Platinum Investment Management held 106 positions worth $4.47B, up 5% from $4.25B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Platinum Investment Management deployed $244M of net new capital in Q3 2019, opening 9 new positions and adding to 24 existing holdings. Its largest new stake was Trip.com Group: 425,412 shares worth $12.5M.

By sector, the portfolio is most concentrated in Communication Services at 26% of assets, down from 27% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $40.6M trimmed.

  • Platinum Investment Management's largest Q3 2019 buy was Trip.com Group: 425,412 shares worth $12.5M.
  • Platinum Investment Management added most to Alibaba in Q3 2019, an estimated $117M increase.
  • Platinum Investment Management's biggest Q3 2019 reduction was Meta Platforms (Facebook), cutting an estimated $40.6M.
  • Platinum Investment Management fully exited Owens Corning in Q3 2019, selling an estimated $91.9M.
  • Platinum Investment Management's ten largest holdings make up 57% of its $4.47B portfolio in Q3 2019.
  • Platinum Investment Management opened 9 new positions and closed 7 in Q3 2019.
  • Platinum Investment Management's portfolio value rose 5% quarter-over-quarter to $4.47B.

Based on Platinum Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.